IRadimed
Update in progressIRMD (NasdaqGM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
IRADIMED CORPORATION develops and markets MRI‑compatible intravenous infusion pumps, patient monitoring systems, and related accessories. Its products include MRidium 3870 and 3860+ MRI‑compatible IV pumps with disposable tubing, the 3880 MRI patient monitor, and the 3600 FMD1 ferromagnetic detection device with remote alarm logging. The company also offers non‑magnetic IV poles, wireless displays, dose‑error reduction, and SpO2 sensors. Serving hospitals and imaging centers worldwide, IRADIMED sells through direct and distributor channels. Based in Orlando since 1992.
Company score
- Sentiment
- 0.44
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.02
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.30
- Governance
- 0.14
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.11
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.27
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGM (NGM)
- LocationUnited States
- CEOMr. Roger E. Susi
- Founded1992
- Employees166
- Websitewww.iradimed.com
Identifiers
- ISINUS46266A1097
- FIGIBBG006NM92X2
- LEI549300YVHWP0YJ1YW816
- CUSIP46266A109
- CIK0001325618